ReviewInternational ophthalmology2021

Teprotumumab (Tepezza): from the discovery and development of medicines to USFDA approval for active thyroid eye disease (TED) treatment.

Faraat Ali et al.PubMed ↗Publisher ↗

No numbers read from the abstract.